Mrinalini Dey DrMiniDey
3 years 6 months ago
#ACR20 Closing Session: really poignant words from Dr Diane Kamen:
"This meeting...allowed people to 'go to the microphones'...people who wouldn't normally get up and ask questions during the sessions...allowed for a lot more exchange of ideas."
Couldn't agree more!
@RheumNow
Vaccination with Shingrix: Does it work for patients on JAKi?
Dr. Jeffrey Curtis examines abstracts #1997 and #0452 presented at the ACR 2020 annual meeting.
Giant Cell Arteritis Panel
Panelists Dr. Richard Conway, Dr. David Liew, Dr. Sarah Mackie and Dr. Len Calabrese discuss giant cell arteritis studies presented at the 2020 ACR annual meeting.
Patient Outcomes on Low-Dose Steroids: Dr. Eric Dein
Dr. Eric Dein reviews abstract #1998 presented at the 2020 ACR annual meeting.
Mid-Meeting Recap: Gout
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss gout studies presented at ACR 2020 with Dr. Michael Pillinger and Dr. Bella Mehta.
Mid-Meeting Recap: Psoriatic Arthritis
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss psoriatic arthritis reports from ACR 2020 with Dr. Eric Ruderman and Dr. Robert Chao.
Mid-Meeting Recap: Rheumatoid Arthritis
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss rheumatoid arthritis studies presented at ACR 2020 with Dr. Kathryn Dao and Dr. Jonathan Kay.
Mid Meeting Recap: Spondyloarthritis
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss AS/SpA reports from ACR 2020 with Dr. John Reveille and Dr. Olga Petryna.
Janet Pope Janetbirdope
3 years 6 months ago
What would you use in multidrug failure RA pt from last tweet +RF nodules & keratitis failed 2 TNFi & 2 JAKi @RheumNow #ACR20 @CRASCRRheum
David Liew drdavidliew
3 years 6 months ago
Low-dose steroids in RA: what's the harm, right?
(You probably know where I'm going with this)
ESPOIR 10y data: total events, and severe infections worse with dose and time
(cumulative 8.4g ≡ 5mg/d)
No doubt some residual confounding, but real risk!
#ACR20 ABST1998 @RheumNow https://t.co/BAQmOR1ped
Janet Pope Janetbirdope
3 years 6 months ago
What would you use next? sero+ RA new keratitis requiring prednisone and now also 20 SJC. New rheumatoid nodules. Pt has been on triple csDMARDs + Leflunomide, then 2 JAKi and 2 TNFi also with MTX each time. All Rx works for 6 months then relapse. @RheumNow @CRASCRRheum https://t.co/9cTS1tNE42
Janet Pope Janetbirdope
3 years 6 months ago
Filgo decreased MRI inflammation of many structures early in Rx in SpA which seems novel says w Maksymowych 5M015 @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/LOOOn7Hjvp
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 6 months ago
Inadequate response to MTX, what next?
“Are you forward thinking or are you stuck in the past? Conceptually it is just amazing that you can take a PO tablet as potent as a TNF or IL6 blocker... & the side effects are not so appalling.”—Dr. GreggSilverman. @RheumNow
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 6 months ago
Summary of #ACR20 part C:
- A must see talk was the avacopan story
- IVIG for myositis does work! More than just anecdotal evidence now
- DIET is key to helping improve autoimmune dz!
- low dz activity RA pts should taper off of MTX 1st when also on TNFi @jeffsparks @RheumNow
Olga Petryna DrPetryna
3 years 6 months ago
@RheumNow #ACR20 abs1923 prosp cohort study of angiographic lesions in Takayasu’ &GCA: although infrequent new angio lesions more likely in TAK. Improvement is possible in both conditions, more likely to occur in TAK. Change in the branch arteries more dynamic than in the aorta https://t.co/2KsZ6o3vtP
Poster Hall